标题
Potential therapeutic targets in plasma cell disorders: A flow cytometry study
作者
关键词
-
出版物
CYTOMETRY PART B-CLINICAL CYTOMETRY
Volume 92, Issue 2, Pages 145-152
出版商
Wiley
发表日期
2015-12-15
DOI
10.1002/cyto.b.21351
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
- (2015) Sagar Lonial et al. NEW ENGLAND JOURNAL OF MEDICINE
- Robust isolation of malignant plasma cells in multiple myeloma
- (2014) I. Frigyesi et al. BLOOD
- Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways
- (2014) Balaji Balasa et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Brentuximab vedotin: An anti-CD30 antibody-drug conjugate
- (2013) A. M. Bradley et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- The novel proteasome inhibitor carfilzomib induces cell cycle arrest, apoptosis and potentiates the anti-tumour activity of chemotherapy in rituximab-resistant lymphoma
- (2013) Juan J. Gu et al. BRITISH JOURNAL OF HAEMATOLOGY
- Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC
- (2013) Shauna M. Collins et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Potential therapeutic biomarkers in plasma cell myeloma: A flow cytometry study
- (2013) Wenli Zheng et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- CD30: from basic research to cancer therapy
- (2013) Hiromi Muta et al. IMMUNOLOGIC RESEARCH
- Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
- (2013) Andy C. Rawstron et al. JOURNAL OF CLINICAL ONCOLOGY
- t(11;14) multiple myeloma: A subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome
- (2013) Gang An et al. LEUKEMIA RESEARCH
- Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells
- (2013) Hua Jiang et al. Molecular Oncology
- Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients
- (2012) B Paiva et al. LEUKEMIA
- Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14)
- (2011) T. Bochtler et al. BLOOD
- Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p
- (2011) K. Neben et al. BLOOD
- Immunophenotyping in multiple myeloma and related plasma cell disorders
- (2010) Shaji Kumar et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders
- (2010) Karthick R. M. Raja et al. BRITISH JOURNAL OF HAEMATOLOGY
- Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma
- (2010) Hans E. Johnsen et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukaemia and lymphoma
- (2009) Akihiro Takeshita et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immunophenotype of neoplastic plasma cells in AL amyloidosis
- (2009) M Deshmukh et al. JOURNAL OF CLINICAL PATHOLOGY
- CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma
- (2008) E. D. Hsi et al. CLINICAL CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started